With a New Diabetes Product Coming to Market, What Lies Ahead for Zealand Pharma Investors?

Jia Jie Chen, The Motley Fool
·4-min read
With a New Diabetes Product Coming to Market, What Lies Ahead for Zealand Pharma Investors?

A new, easier-to-administer treatment for severe hypoglycemia has observers and investors wondering where its creators will go next.